Janux Therapeutics (JANX) Institutional Ownership
13F filers reported holding 100.1% of Janux Therapeutics (JANX) shares as of Jun 30, 2026, across 199 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 100.1%
- Jun 30, 2026
- 13F filers
- 199
- quarter ended Jun 30, 2026
- 13F value
- $940.8M
- 61.2M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Campbell David Alan | President and CEO | Disposed · Gift | 123,840 | — | ↗ |
| Jul 8, 2026 | Campbell David Alan | President and CEO | Acquired · Option exercise | 7,000 | $4.21 | ↗ |
| Jul 8, 2026 | Campbell David Alan | President and CEO | Disposed · Option exercise | 7,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Simson Jake | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | Simson Jake | director | Acquired · Grant / award | 15,500Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Hernday Natasha | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | Hernday Natasha | director | Acquired · Grant / award | 15,500Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Kung Winston | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | Kung Winston | director | Acquired · Grant / award | 15,500Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Barrett Ronald W | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | Barrett Ronald W | director | Acquired · Grant / award | 15,500Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | CAPPS VICKIE L | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | CAPPS VICKIE L | director | Acquired · Grant / award | 15,500Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, LLC | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, LLC | director | Acquired · Grant / award | 15,500Stock Option (Right to Buy) | — | ↗ |
| Jun 11, 2026 | DOBMEIER ERIC | director | Acquired · Grant / award | 5,500 | — | ↗ |
| Jun 11, 2026 | DOBMEIER ERIC | director | Acquired · Grant / award | 15,500Stock Option (right to buy) | — | ↗ |
| Jun 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Disposed · Open-market sale | 4,059 | $14.03 | ↗ |
| May 11, 2026 | Dobek Maria | Vice President, Accounting | Disposed · Open-market sale | 2,038 | $14.17 | ↗ |
| Feb 2, 2026 | Go William | Chief Medical Officer | Acquired · Grant / award | 44,000 | — | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Janux Therapeutics do institutions hold?
13F filers reported holding 100.1% of Janux Therapeutics' shares as of Jun 30, 2026, across 199 filers.
How many 13F filers hold Janux Therapeutics?
Janux Therapeutics was held by 199 13F filers as of Jun 30, 2026.
Not investment advice.

